 ALPHARETTA, Ga., Aug. 23, 2021 GLOBE NEWSWIRE -- Clearside Biomedical, Inc. NASDAQ:CLSD, a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will present a company overview at the Ophthalmology Futures European 2021 Virtual Retina Forum on September 8, 2021. Access to the event is available here. 